Peter Voorhees
0000-0001-5377-8535
2 papers found
Refreshing results…
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long‐term survival follow‐up from the Phase II study O‐12‐M1
Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma
Missing publications? Search for publications with a matching author name.